Xponance, Inc. Ligand Pharmaceuticals Inc Transaction History

Xponance, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$102.33 - $144.73 $261,146 - $369,350	-2,552 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$113.03 - $155.64 $82,172 - $113,150	727 Added 39.84%	2,552 $335,000
Q1 2021 May 10, 2021	SELL	$99.52 - $215.83 $28,064 - $60,864	-282 Reduced 13.38%	1,825 $278,000
Q4 2020 Feb 11, 2021	SELL	$80.55 - $106.05 $2,497 - $3,287	-31 Reduced 1.45%	2,107 $210,000
Q3 2020 Oct 26, 2020	BUY	$89.56 - $126.72 $3,045 - $4,308	34 Added 1.62%	2,138 $204,000
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $143,661 - $260,159	2,104 New	2,104 $235,000

262

18M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.